In allogeneic transplants, it is crucial to match the donor's human leukocyte antigen (HLA) type with the recipient's HLA type. This minimizes the risk of graft-versus-host disease (GVHD), where the donated cells attack the recipient's body. Matching is typically done through blood tests and may involve siblings, other relatives, or unrelated donors.
